Baquero, Juan Miguel
Benítez-Buelga, Carlos
Rajagopal, Varshni
Zhenjun, Zhao
Torres-Ruiz, Raúl
Müller, Sarah
Hanna, Bishoy M. F.
Loseva, Olga
Wallner, Olov
Michel, Maurice
Rodríguez-Perales, Sandra
Gad, Helge
Visnes, Torkild
Helleday, Thomas
Benítez, Javier
Osorio, Ana
Article History
Received: 9 September 2020
Accepted: 18 January 2021
First Online: 10 February 2021
Competing interests
: T.H. and T.V are listed as inventors on a provisional U.S. patent application no. 62/636983, covering OGG1 inhibitors. The patent is fully owned by a non-profit public foundation, the Helleday Foundation, and T.H., H.G. are members of the foundation board developing OGG1 inhibitors toward the clinic. The remaining authors declare no competing financial interests.